Archive - February 24, 2016

The new NICE CGM guidelines: what do they mean for me?

On February 12, 2016, the National Institute for Health and Care Excellence (NICE) published ‘Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system‘. In this 49-page document, NICE outlined recommendations to provide technology to certain people with type 1 diabetes to help them control their blood glucose levels.

We’ve trawled through the recommendations so you don’t have to. In this blog, we’ll answer the big questions surrounding the recommendations: Who is eligible? What exactly are they eligible for? Is it likely that the system will be made widely available in the future?

Read More

Copyright © 2018